J&J Procrit Medicare Reimbursement Will Be 87% Of AWP Under Final Rule
Executive Summary
Johnson & Johnson's Procrit will be reimbursed at 87% of average wholesale price under Medicare Part B in 2004, two percentage points higher than most drugs
You may also be interested in...
Part B Drug Use “Substantially” Higher In 2004, CMS Says
Use of physician-administered drugs under Medicare Part B increased "substantially" in 2004, the Centers for Medicare & Medicaid Services told the Medicare Payment Advisory Commission March 31
Part B Drug Use “Substantially” Higher In 2004, CMS Says
Use of physician-administered drugs under Medicare Part B increased "substantially" in 2004, the Centers for Medicare & Medicaid Services told the Medicare Payment Advisory Commission March 31
FluMist Price Likely To Be Cut To $20-$25 Per Dose, MedImmune Says
MedImmune is considering reducing the price for the intranasal flu vaccine FluMist to $20-$25 per dose for the 2004-2005 season, CEO David Mott indicated during a first quarter conference call April 21